{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:50:54Z","timestamp":1790711454629,"version":"4.1.0"},"reference-count":140,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Hubei Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2025AFB817"],"award-info":[{"award-number":["2025AFB817"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472227"],"award-info":[{"award-number":["82472227"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372188"],"award-info":[{"award-number":["82372188"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172160"],"award-info":[{"award-number":["82172160"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.phrs.2026.108434","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T06:30:43Z","timestamp":1788503443000},"page":"108434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Cardiomyocyte calcium homeostasis remodeling in diabetes-related HFpEF: mechanisms and therapeutic perspectives"],"prefix":"10.1016","volume":"232","author":[{"given":"Kexin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-yuan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2026.108434_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-8587(14)70219-0","article-title":"Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1\u00b79 million people","volume":"3","author":"Shah","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.phrs.2026.108434_bib2","article-title":"IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2021","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.phrs.2026.108434_bib3","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1007\/s00125-008-1164-z","article-title":"HbA1c as a risk factor for heart failure in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) study","volume":"51","author":"Filho","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2026.108434_bib4","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1007\/s00125-019-4926-x","article-title":"Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals","volume":"62","author":"Ohkuma","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2026.108434_bib5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4093\/dmj.2020.0282","article-title":"Epidemiology, Pathophysiology, Diagnosis and Treatment of Heart Failure in Diabetes","volume":"45","author":"Park","year":"2021","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.phrs.2026.108434_bib6","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.2023.2020","article-title":"Heart Failure With Preserved Ejection Fraction: A Review","volume":"329","author":"Redfield","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2026.108434_bib7","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jacc.2018.11.033","article-title":"Heart Failure With Preserved Ejection Fraction and Diabetes","volume":"73","author":"McHugh","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2026.108434_bib8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cardfail.2018.10.015","article-title":"Heart Failure Epidemiology in Patients With Diabetes Mellitus Without Coronary Heart Disease","volume":"25","author":"Khan","year":"2019","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.phrs.2026.108434_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjac028","article-title":"Heart failure with preserved ejection fraction (HFpEF) in type 2 diabetes mellitus: from pathophysiology to therapeutics","volume":"14","author":"Abudureyimu","year":"2022","journal-title":"J. Mol. Cell. Biol."},{"key":"10.1016\/j.phrs.2026.108434_bib10","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(23)02756-3","article-title":"Heart failure with preserved ejection fraction: everything the clinician needs to know","volume":"403","author":"Campbell","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2026.108434_bib11","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"ESC Scientific Document Group, 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2026.108434_bib12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cardfail.2021.01.022","volume":"27","author":"Bozkurt","year":"2021","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.phrs.2026.108434_bib13","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in Heart Failure with a Preserved Ejection Fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2026.108434_bib14","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2026.108434_bib15","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jchf.2023.02.006","article-title":"SERCA2a Agonist Effects on Cardiac Performance During Exercise in Heart Failure With Preserved Ejection Fraction","volume":"11","author":"Sarma","year":"2023","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.phrs.2026.108434_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/jcdd11010012","article-title":"Myocardial Calcium Handling in Type 2 Diabetes: A Novel Therapeutic Target","volume":"11","author":"Dattani","year":"2023","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"10.1016\/j.phrs.2026.108434_bib17","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3389\/fphys.2018.01517","article-title":"Proarrhythmic Remodeling of Calcium Homeostasis in Cardiac Disease; Implications for Diabetes and Obesity","volume":"9","author":"Hamilton","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phrs.2026.108434_bib18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/lifemeta\/loac013","article-title":"Impaired SERCA2a phosphorylation causes diabetic cardiomyopathy through impinging on cardiac contractility and precursor protein processing","volume":"1","author":"Quan","year":"2022","journal-title":"Life Metab."},{"key":"10.1016\/j.phrs.2026.108434_bib19","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.166713","article-title":"Cardiac gene therapy treats diabetic cardiomyopathy and lowers blood glucose","volume":"8","author":"Li","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.phrs.2026.108434_bib20","article-title":"Post-translational modifications in diabetic cardiomyopathy","volume":"28","author":"Li","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.phrs.2026.108434_bib21","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/cvr\/27.10.1826","article-title":"The relative contributions of different intracellular and sarcolemmal systems to relaxation in rat ventricular myocytes","volume":"27","author":"Negretti","year":"1993","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2026.108434_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1942086","article-title":"Calcium Homeostasis in Ventricular Myocytes of Diabetic Cardiomyopathy","volume":"2020","author":"Al Kury","year":"2020","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.phrs.2026.108434_bib23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10741-020-10042-0","article-title":"Mechanisms underlying the pathophysiology of heart failure with preserved ejection fraction: the tip of the iceberg","volume":"26","author":"Miranda-Silva","year":"2021","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.phrs.2026.108434_bib24","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10741-022-10271-5","article-title":"Diabetes-induced chronic heart failure is due to defects in calcium transporting and regulatory contractile proteins: cellular and molecular evidence","volume":"28","author":"Rupee","year":"2023","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.phrs.2026.108434_bib25","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3389\/fphys.2019.00733","article-title":"Mitofusin 2 Is Essential for IP3-Mediated SR\/Mitochondria Metabolic Feedback in Ventricular Myocytes","volume":"10","author":"Seidlmayer","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phrs.2026.108434_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13378","article-title":"Disturbed cardiac mitochondrial and cytosolic calcium handling in a metabolic risk-related rat model of heart failure with preserved ejection fraction","volume":"228","author":"Miranda-Silva","year":"2020","journal-title":"Acta Physiol."},{"key":"10.1016\/j.phrs.2026.108434_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165984","article-title":"Mitochondrial calcium handling and heart disease in diabetes mellitus","volume":"1867","author":"Diaz-Juarez","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.phrs.2026.108434_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2026.05.004","article-title":"Restoration of mitochondrial Ca2+ and redox homeostasis by enhancement of SK channels rescues Ca2+ cycling in HFpEF cardiomyocytes","volume":"216","author":"Hamilton","year":"2026","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.phrs.2026.108434_bib29","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1161\/CIRCULATIONAHA.119.041886","article-title":"Research Priorities for Heart Failure with Preserved Ejection Fraction: National Heart, Lung, and Blood Institute Working Group Summary","volume":"141","author":"Shah","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2026.108434_bib30","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2026.108434_bib31","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.2013.2024","article-title":"Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure with Preserved Ejection Fraction: A Randomized Clinical Trial","volume":"309","author":"Redfield","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2026.108434_bib32","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for Heart Failure with Preserved Ejection Fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2026.108434_bib33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A Novel Paradigm for Heart Failure With Preserved Ejection Fraction: Comorbidities Drive Myocardial Dysfunction and Remodeling Through Coronary Microvascular Endothelial Inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2026.108434_bib34","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/CIRCHEARTFAILURE.109.930701","article-title":"Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure with Preserved Ejection Fraction","volume":"3","author":"Borlaug","year":"2010","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.phrs.2026.108434_bib35","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jacc.2010.04.040","article-title":"Hemodynamic Basis of Exercise Limitation in Patients With Heart Failure and Normal Ejection Fraction","volume":"56","author":"Maeder","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2026.108434_bib36","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation\u2013contraction coupling","volume":"415","author":"Bers","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.108434_bib37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/CIRCRESAHA.117.310230","article-title":"Calcium and Excitation-Contraction Coupling in the Heart","volume":"121","author":"Eisner","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2026.108434_bib38","first-page":"632","article-title":"Heart Failure With Preserved Ejection Fraction in Diabetes: Mechanisms and Management","volume":"34","author":"Meagher","year":"2018","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.phrs.2026.108434_bib39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","article-title":"Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease","volume":"61","author":"Jia","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2026.108434_bib40","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2337\/db10-1145","article-title":"Carbonylation Contributes to SERCA2a Activity Loss and Diastolic Dysfunction in a Rat Model of Type 1 Diabetes","volume":"60","author":"Shao","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2026.108434_bib41","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3389\/fphys.2012.00292","article-title":"Advanced glycation end product cross-link breaker attenuates diabetes-induced cardiac dysfunction by improving sarcoplasmic reticulum calcium handling","volume":"3","author":"Kranstuber","year":"2012","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phrs.2026.108434_bib42","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.3390\/ijms20133264","article-title":"Molecular Dysfunction and Phenotypic Derangement in Diabetic Cardiomyopathy","volume":"20","author":"Evangelista","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108434_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adm8842","article-title":"Vasohibin inhibition improves myocardial relaxation in a rat model of heart failure with preserved ejection fraction","volume":"16","author":"Eaton","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.phrs.2026.108434_bib44","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ijcard.2015.09.022","article-title":"Ryanodine receptor phosphorylation by CaMKII promotes spontaneous Ca2+ release events in a rodent model of early stage diabetes: The arrhythmogenic substrate","volume":"202","author":"Sommese","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.phrs.2026.108434_bib45","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jchf.2015.10.007","article-title":"Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction","volume":"4","author":"Franssen","year":"2016","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.phrs.2026.108434_bib46","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1161\/CIRCHEARTFAILURE.113.000539","article-title":"Myocardial Titin Hypophosphorylation Importantly Contributes to Heart Failure With Preserved Ejection Fraction in a Rat Metabolic Risk Model","volume":"6","author":"Hamdani","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.phrs.2026.108434_bib47","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1124\/mol.112.078352","article-title":"Carbonylation induces heterogeneity in cardiac ryanodine receptor function in diabetes mellitus","volume":"82","author":"Shao","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108434_bib48","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jacbts.2020.11.002","article-title":"Interleukin-1\u03b2, Oxidative Stress, and Abnormal Calcium Handling Mediate Diabetic Arrhythmic Risk","volume":"6","author":"Liu","year":"2021","journal-title":"JACC Basic. Transl. Sci."},{"key":"10.1016\/j.phrs.2026.108434_bib49","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.2337\/diabetes.53.12.3201","article-title":"Decreased sarcoplasmic reticulum activity and contractility in diabetic db\/db mouse heart","volume":"53","author":"Belke","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2026.108434_bib50","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jacc.2020.11.044","article-title":"Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction","volume":"77","author":"Frisk","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2026.108434_bib51","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1254\/jphs.CPJ06009X","article-title":"Signal transduction and Ca2+ signaling in intact myocardium","volume":"100","author":"Endoh","year":"2006","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2026.108434_bib52","doi-asserted-by":"crossref","first-page":"H348","DOI":"10.1152\/ajpheart.00227.2025","article-title":"Excitation-contraction coupling, cardiomyocyte electrophysiology, and transcriptome profiles in two HFpEF murine models: Etiology and sex-dependent differences","volume":"330","author":"Hegyi","year":"2026","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2026.108434_bib53","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrm1151","article-title":"Phospholamban: a crucial regulator of cardiac contractility","volume":"4","author":"MacLennan","year":"2003","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.phrs.2026.108434_bib54","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10741-025-10487-1","article-title":"SERCA2a dysfunction in the pathophysiology of heart failure with preserved ejection fraction: a direct role is yet to be established","volume":"30","author":"Shooshtarian","year":"2025","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.phrs.2026.108434_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107267","article-title":"Phospholamban inhibits the cardiac calcium pump by interrupting an allosteric activation pathway","volume":"300","author":"Cleary","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2026.108434_bib56","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/cvr\/cvad178","article-title":"Remodelling of cAMP dynamics within the SERCA2a microdomain in heart failure with preserved ejection fraction caused by obesity and type 2 diabetes","volume":"120","author":"Lai","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2026.108434_bib57","doi-asserted-by":"crossref","first-page":"R1787","DOI":"10.1152\/ajpregu.00059.2007","article-title":"Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes","volume":"293","author":"Lacombe","year":"2007","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.phrs.2026.108434_bib58","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/cvr\/cvae070","article-title":"Differential sex-dependent susceptibility to diastolic dysfunction and arrhythmia in cardiomyocytes from obese diabetic heart failure with preserved ejection fraction model","volume":"121","author":"Mira Hernandez","year":"2025","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2026.108434_bib59","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ceca.2014.09.005","article-title":"Regulation of SERCA pumps expression in diabetes","volume":"56","author":"Zarain-Herzberg","year":"2014","journal-title":"Cell. Calcium"},{"key":"10.1016\/j.phrs.2026.108434_bib60","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/bph.17411","article-title":"Inhibition of the upregulated phosphodiesterase 4D isoforms improves SERCA2a function in diabetic cardiomyopathy","volume":"182","author":"Zhu","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108434_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006474","article-title":"Gene Remodeling in Type 2 Diabetic Cardiomyopathy and Its Phenotypic Rescue with SERCA2a","volume":"4","author":"Karakikes","year":"2009","journal-title":"PLoS. ONE"},{"key":"10.1016\/j.phrs.2026.108434_bib62","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.bbrc.2012.08.130","article-title":"Role of the Na+\/Ca2+ exchanger on the development of diabetes mellitus and its chronic complications","volume":"426","author":"Cui","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2026.108434_bib63","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1113\/EP086534","article-title":"Crosslink between calcium and sodium signalling","volume":"103","author":"Verkhratsky","year":"2018","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.phrs.2026.108434_bib64","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/jdi.13451","article-title":"Calcium signaling in endocardial and epicardial ventricular myocytes from streptozotocin-induced diabetic rats","volume":"12","author":"Al Kury","year":"2021","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.phrs.2026.108434_bib65","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0008-6363(97)00020-5","article-title":"Mechanisms underlying depressed Na+\/Ca2+ exchanger activity in the diabetic heart","volume":"34","author":"Schaffer","year":"1997","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2026.108434_bib66","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-201x.1999.00547.x","article-title":"Decrease in sodium-calcium exchange and calcium currents in diabetic rat ventricular myocytes","volume":"166","author":"Chattou","year":"1999","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.phrs.2026.108434_bib67","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1469-7793.2000.00085.x","article-title":"Diminished function and expression of the cardiac Na+-Ca2+ exchanger in diabetic rats: implication in Ca2+ overload","volume":"527","author":"Hattori","year":"2000","journal-title":"J. Physiol."},{"key":"10.1016\/j.phrs.2026.108434_bib68","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00125-016-4134-x","article-title":"Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+\/H+ exchanger in rats and rabbits","volume":"60","author":"Baartscheer","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2026.108434_bib69","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3389\/fphys.2018.01473","article-title":"The Role of Sodium in Diabetic Cardiomyopathy","volume":"9","author":"Doliba","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phrs.2026.108434_bib70","doi-asserted-by":"crossref","first-page":"8080","DOI":"10.1038\/s41467-024-51791-y","article-title":"Structural basis for ryanodine receptor type 2 leak in heart failure and arrhythmogenic disorders","volume":"15","author":"Miotto","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108434_bib71","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41569-020-0394-8","article-title":"Intracellular calcium leak in heart failure and atrial fibrillation: a unifying mechanism and therapeutic target","volume":"17","author":"Dridi","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.phrs.2026.108434_bib72","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jjcc.2025.02.003","article-title":"Structural instability of ryanodine receptor 2 causes endoplasmic reticulum (ER) dysfunction as well as sarcoplasmic reticulum (SR) dysfunction","volume":"85","author":"Uchinoumi","year":"2025","journal-title":"J. Cardiol."},{"key":"10.1016\/j.phrs.2026.108434_bib73","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1024738706470","article-title":"Chronic diabetes alters function and expression of ryanodine receptor calcium-release channels in rat hearts","volume":"249","author":"Bidasee","year":"2003","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.phrs.2026.108434_bib74","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.3390\/ijms20071680","article-title":"Empagliflozin Attenuates Myocardial Sodium and Calcium Dysregulation and Reverses Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats","volume":"20","author":"Lee","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108434_bib75","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.027164","article-title":"Diabetes and Excess Aldosterone Promote Heart Failure With Preserved Ejection Fraction","volume":"11","author":"Hegyi","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.phrs.2026.108434_bib76","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1006\/jmcc.2000.1107","article-title":"Diminished Expression of Sarcoplasmic Reticulum Ca2+-ATPase and Ryanodine Sensitive Ca2+Channel mRNA in Streptozotocin-induced Diabetic Rat Heart","volume":"32","author":"Teshima","year":"2000","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.phrs.2026.108434_bib77","doi-asserted-by":"crossref","first-page":"H1398","DOI":"10.1152\/ajpheart.00313.2002","article-title":"Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in Type 1 diabetic rats","volume":"283","author":"Choi","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2026.108434_bib78","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.2337\/diabetes.54.11.3082","article-title":"Effects of diabetes on ryanodine receptor Ca release channel (RyR2) and Ca2+ homeostasis in rat heart","volume":"54","author":"Yaras","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2026.108434_bib79","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1475-2840-13-75","article-title":"Progressive decay of Ca2+ homeostasis in the development of diabetic cardiomyopathy","volume":"13","author":"Zhao","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.phrs.2026.108434_bib80","doi-asserted-by":"crossref","first-page":"16142","DOI":"10.3390\/ijms242216142","article-title":"Ketogenic Diet Regulates Cardiac Remodeling and Calcium Homeostasis in Diabetic Rat Cardiomyopathy","volume":"24","author":"Lee","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108434_bib81","doi-asserted-by":"crossref","first-page":"H341","DOI":"10.1152\/ajpheart.00391.2022","article-title":"Empagliflozin attenuates arrhythmogenesis in diabetic cardiomyopathy by normalizing intracellular Ca2+ handling in ventricular cardiomyocytes","volume":"324","author":"Kadosaka","year":"2023","journal-title":"Am. J. Physiol. -Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2026.108434_bib82","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5732956","article-title":"The Role of Oxidative Stress in Cardiac Disease: From Physiological Response to Injury Factor","volume":"2020","author":"D\u2019Oria","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.phrs.2026.108434_bib83","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12933-023-02010-3","article-title":"Direct regulation of the cardiac ryanodine receptor (RyR2) by O-GlcNAcylation","volume":"22","author":"Okolo","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.phrs.2026.108434_bib84","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.yjmcc.2011.08.014","article-title":"Different Subcellular Populations of L-type Ca2+ Channels Exhibit Unique Regulation and Functional Roles in Cardiomyocytes","volume":"52","author":"Best","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.phrs.2026.108434_bib85","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.3390\/ijms26125738","article-title":"Molecular Mechanisms of L-Type Calcium Channel Dysregulation in Heart Failure","volume":"26","author":"Khalid","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108434_bib86","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.2337\/db12-1391","article-title":"Hyperglycemia-Induced Protein Kinase C \u03b22 Activation Induces Diastolic Cardiac Dysfunction in Diabetic Rats by Impairing Caveolin-3 Expression and Akt\/eNOS Signaling","volume":"62","author":"Lei","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2026.108434_bib87","article-title":"The Physiology and Pathophysiology of T-Tubules in the Heart","volume":"12","author":"Setterberg","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phrs.2026.108434_bib88","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.yjmcc.2009.03.015","article-title":"Mitochondrial Free Calcium Regulation during Sarcoplasmic Reticulum Calcium Release in Rat Cardiac Myocytes","volume":"46","author":"Andrienko","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.phrs.2026.108434_bib89","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1113\/JP273589","article-title":"Rapid frequency-dependent changes in free mitochondrial calcium concentration in rat cardiac myocytes","volume":"595","author":"W\u00fcst","year":"2017","journal-title":"J. Physiol."},{"key":"10.1016\/j.phrs.2026.108434_bib90","doi-asserted-by":"crossref","first-page":"8182","DOI":"10.1074\/jbc.RA118.002066","article-title":"Restoring mitochondrial calcium uniporter expression in diabetic mouse heart improves mitochondrial calcium handling and cardiac function","volume":"293","author":"Suarez","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2026.108434_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fmmed.2023.1235188","article-title":"Mitochondrial calcium signaling and redox homeostasis in cardiac health and disease","volume":"3","author":"Popoiu","year":"2023","journal-title":"Front. Mol. Med."},{"key":"10.1016\/j.phrs.2026.108434_bib92","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1152\/physrev.00041.2020","article-title":"Mitochondrial calcium exchange in physiology and disease","volume":"102","author":"Garbincius","year":"2022","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2026.108434_bib93","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1073\/pnas.0908099107","article-title":"NCLX is an essential component of mitochondrial Na+\/Ca2+ exchange","volume":"107","author":"Palty","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2026.108434_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055785","article-title":"MICU2, a Paralog of MICU1, Resides within the Mitochondrial Uniporter Complex to Regulate Calcium Handling","volume":"8","author":"Plovanich","year":"2013","journal-title":"PLoS. ONE"},{"key":"10.1016\/j.phrs.2026.108434_bib95","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIRCRESAHA.116.305484","article-title":"The Ins and Outs of Mitochondrial Calcium","volume":"116","author":"Finkel","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2026.108434_bib96","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2337\/db20-0779","article-title":"Ncor2\/PPAR\u03b1-Dependent Upregulation of MCUb in the Type 2 Diabetic Heart Impacts Cardiac Metabolic Flexibility and Function","volume":"70","author":"Cividini","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2026.108434_bib97","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.029997","article-title":"Distinct Effects of Mitochondrial Na+\/Ca2+ Exchanger Inhibition and Ca2+ Uniporter Activation on Ca2+ Sparks and Arrhythmogenesis in Diabetic Rats","volume":"12","author":"Velmurugan","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.phrs.2026.108434_bib98","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/01.RES.76.5.790","article-title":"Effects of Action Potential Duration on Excitation-Contraction Coupling in Rat Ventricular Myocytes","volume":"76","author":"Bouchard","year":"1995","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2026.108434_bib99","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00395-024-01067-9","article-title":"Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2","volume":"119","author":"Chen","year":"2024","journal-title":"Basic. Res. Cardiol."},{"key":"10.1016\/j.phrs.2026.108434_bib100","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.011107","article-title":"Empagliflozin Improves Diastolic Function in HFpEF by Restabilizing the Mitochondrial Respiratory Chain","volume":"17","author":"Schauer","year":"2024","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.phrs.2026.108434_bib101","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/ejhf.3644","article-title":"Cardioprotective effects of semaglutide on isolated human ventricular myocardium","volume":"27","author":"Krammer","year":"2025","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.phrs.2026.108434_bib102","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1056\/NEJMoa2313917","article-title":"Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes","volume":"390","author":"Kosiborod","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2026.108434_bib103","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/dmrr.322","article-title":"Contributions of endothelin-1 and sodium hydrogen exchanger-1 in the diabetic myocardium","volume":"18","author":"Hileeto","year":"2002","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.phrs.2026.108434_bib104","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00125-007-0628-x","article-title":"Enhanced activity of the myocardial Na+\/H+ exchanger contributes to left ventricular hypertrophy in the Goto\u2013Kakizaki rat model of type 2 diabetes: critical role of Akt","volume":"50","author":"Darmellah","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2026.108434_bib105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1475-2840-11-33","article-title":"The role of Na+\/H+ exchanger in Ca2+ overload and ischemic myocardial damage in hearts from type 2 diabetic db\/db mice","volume":"11","author":"Anzawa","year":"2012","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.phrs.2026.108434_bib106","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s00125-017-4509-7","article-title":"Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+\/H+ exchanger, lowering of cytosolic Na+ and vasodilation","volume":"61","author":"Uthman","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2026.108434_bib107","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/cvr\/cvae095","article-title":"Empagliflozin inhibits increased Na influx in atrial cardiomyocytes of patients with HFpEF","volume":"120","author":"Trum","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2026.108434_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112515","article-title":"Empagliflozin reduces oxidative stress through inhibition of the novel inflammation\/NHE\/[Na+]c\/ROS-pathway in human endothelial cells","volume":"146","author":"Uthman","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2026.108434_bib109","article-title":"Empagliflozin prevents oxidative stress in human coronary artery endothelial cells via the NHE\/PKC\/NOX axis","volume":"69","author":"Li","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.phrs.2026.108434_bib110","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2026.1716764","article-title":"Direct dapagliflozin exposure enhances respiration and membrane hyperpolarization in isolated cardiac mitochondria","volume":"17","author":"de Souza","year":"2026","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phrs.2026.108434_bib111","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.124.069732","article-title":"Randomized Crossover Trial of 2-Week Ketone Ester Treatment in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction","volume":"150","author":"Gopalasingam","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2026.108434_bib112","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/CIRCULATIONAHA.115.017355","article-title":"The Failing Heart Relies on Ketone Bodies as a Fuel","volume":"133","author":"Aubert","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2026.108434_bib113","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/CIRCULATIONAHA.115.017545","article-title":"Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure","volume":"133","author":"Bedi","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2026.108434_bib114","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/cvr\/cvz045","article-title":"Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency","volume":"115","author":"Ho","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2026.108434_bib115","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020729","article-title":"Ketone Ester D-\u03b2-Hydroxybutyrate-(R)-1,3 Butanediol Prevents Decline in Cardiac Function in Type 2 Diabetic Mice","volume":"10","author":"Thai","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.phrs.2026.108434_bib116","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-physiol-020518-114455","article-title":"Branched Chain Amino Acids","volume":"81","author":"Neinast","year":"2019","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.phrs.2026.108434_bib117","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1002\/ehf2.15285","article-title":"Plasma metabolomics identifies signatures that distinguish heart failure with reduced and preserved ejection fraction","volume":"12","author":"Naeem","year":"2025","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.phrs.2026.108434_bib118","doi-asserted-by":"crossref","first-page":"6257","DOI":"10.7150\/thno.105894","article-title":"BCAA catabolism targeted therapy for heart failure with preserved ejection fraction","volume":"15","author":"Wang","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.phrs.2026.108434_bib119","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.cmet.2016.11.005","article-title":"Defective Branched-Chain Amino Acid (BCAA) Catabolism Disrupts Glucose Metabolism and Sensitizes the Heart to Ischemia-reperfusion Injury","volume":"25","author":"Li","year":"2017","journal-title":"Cell. Metab."},{"key":"10.1016\/j.phrs.2026.108434_bib120","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/s41401-024-01448-9","article-title":"Semaglutide administration protects cardiomyocytes in db\/db mice via energetic improvement and mitochondrial quality control","volume":"46","author":"Tian","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phrs.2026.108434_bib121","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jchf.2023.05.010","article-title":"Design and Baseline Characteristics of STEP-HFpEF Program Evaluating Semaglutide in Patients With Obesity HFpEF Phenotype","volume":"11","author":"Kosiborod","year":"2023","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.phrs.2026.108434_bib122","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1093\/eurheartj\/ehae322","article-title":"Semaglutide and diuretic use in obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF-DM trials","volume":"45","author":"Shah","year":"2024","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2026.108434_bib123","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jacc.2024.04.022","article-title":"Semaglutide and NT-proBNP in Obesity-Related HFpEF","volume":"84","author":"Petrie","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2026.108434_bib124","article-title":"Rhynchophylline Regulates Calcium Homeostasis by Antagonizing Ryanodine Receptor 2 Phosphorylation to Improve Diabetic Cardiomyopathy","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108434_bib125","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1152\/japplphysiol.91280.2008","article-title":"Exercise training during diabetes attenuates cardiac ryanodine receptor dysregulation","volume":"106","author":"Shao","year":"2009","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.phrs.2026.108434_bib126","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.33963\/KP.a2021.0101","article-title":"The effect of exercise training and physiotherapy on diastolic function, exercise capacity and quality of life in patients with heart failure with preserved ejection fraction: a systematic review and meta-analysis","volume":"79","author":"Zhuang","year":"2021","journal-title":"Kardiol. Pol."},{"key":"10.1016\/j.phrs.2026.108434_bib127","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/jama.2020.26812","volume":"325","author":"Mueller","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2026.108434_bib128","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41591-024-03342-7","article-title":"Combined endurance and resistance exercise training in heart failure with preserved ejection fraction: a randomized controlled trial","volume":"31","author":"Edelmann","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2026.108434_bib129","first-page":"e471","article-title":"on behalf of the American Heart Association, Gene Therapy in Cardiovascular Disease: Recent Advances and Future Directions in Science: A Science Advisory From the American Heart Association","volume":"150","author":"Kim","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2026.108434_bib130","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3349\/ymj.2024.0127","article-title":"Gene Therapy for Cardiovascular Disease: Clinical Perspectives","volume":"65","author":"Lee","year":"2024","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.phrs.2026.108434_bib131","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.phrs.2026.108434_bib132","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.111.022889","article-title":"on behalf of the Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID) Investigators, Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID)","volume":"124","author":"Jessup","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2026.108434_bib133","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0140-6736(16)00082-9","article-title":"Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial","volume":"387","author":"Greenberg","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2026.108434_bib134","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.hrthm.2011.11.055","article-title":"BIN1 is reduced and Cav1.2 trafficking is impaired in human failing cardiomyocytes","volume":"9","author":"Hong","year":"2012","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.phrs.2026.108434_bib135","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.115.018535","article-title":"Isoproterenol Promotes Rapid Ryanodine Receptor Movement to BIN1 Organized Dyads","volume":"133","author":"Fu","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2026.108434_bib136","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1161\/CIRCULATIONAHA.123.067504","article-title":"Cardiac Reprogramming and Gata4 Overexpression Reduce Fibrosis and Improve Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction","volume":"151","author":"Yamada","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2026.108434_bib137","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.yjmcc.2005.03.014","article-title":"Impaired SERCA function contributes to cardiomyocyte dysfunction in insulin resistant rats","volume":"39","author":"Wold","year":"2005","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.phrs.2026.108434_bib138","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1093\/cvr\/cvab123","article-title":"SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathy","volume":"118","author":"Torre","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2026.108434_bib139","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1124\/mol.60.6.1356","article-title":"Ryanodine receptor dysfunction in hearts of streptozotocin-induced diabetic rats","volume":"60","author":"Bidasee","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108434_bib140","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2337\/diabetes.55.03.06.db05-1284","article-title":"Mechanisms of [Ca2+]i Transient Decrease in Cardiomyopathy of db\/db Type 2 Diabetic Mice","volume":"55","author":"Pereira","year":"2006","journal-title":"Diabetes"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366182600349X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366182600349X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:01:22Z","timestamp":1789902082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104366182600349X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":140,"alternative-id":["S104366182600349X"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108434","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiomyocyte calcium homeostasis remodeling in diabetes-related HFpEF: mechanisms and therapeutic perspectives","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108434"}}